KR100215533B1 - 아르기닌 아미드 함유 의약 조성물 - Google Patents

아르기닌 아미드 함유 의약 조성물 Download PDF

Info

Publication number
KR100215533B1
KR100215533B1 KR1019940008470A KR19940008470A KR100215533B1 KR 100215533 B1 KR100215533 B1 KR 100215533B1 KR 1019940008470 A KR1019940008470 A KR 1019940008470A KR 19940008470 A KR19940008470 A KR 19940008470A KR 100215533 B1 KR100215533 B1 KR 100215533B1
Authority
KR
South Korea
Prior art keywords
arginine amide
methyl
caffeine
group
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940008470A
Other languages
English (en)
Korean (ko)
Inventor
요시후미 이께지리
사와시로우
Original Assignee
요시다 쇼지
센주 세이야꾸 가부시키가이샤
미우라 아끼라
미쓰비시 가가꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼지, 센주 세이야꾸 가부시키가이샤, 미우라 아끼라, 미쓰비시 가가꾸 가부시키가이샤 filed Critical 요시다 쇼지
Application granted granted Critical
Publication of KR100215533B1 publication Critical patent/KR100215533B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940008470A 1993-04-22 1994-04-21 아르기닌 아미드 함유 의약 조성물 Expired - Fee Related KR100215533B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9627593 1993-04-22
JP93-96275 1993-04-22
JP32476093 1993-12-22
JP93-324760 1993-12-22

Publications (1)

Publication Number Publication Date
KR100215533B1 true KR100215533B1 (ko) 1999-08-16

Family

ID=26437498

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940008470A Expired - Fee Related KR100215533B1 (ko) 1993-04-22 1994-04-21 아르기닌 아미드 함유 의약 조성물

Country Status (8)

Country Link
US (1) US5605892A (enExample)
EP (1) EP0621036B1 (enExample)
KR (1) KR100215533B1 (enExample)
CN (1) CN1054744C (enExample)
AT (1) ATE177635T1 (enExample)
CA (1) CA2121723A1 (enExample)
DE (1) DE69417087T2 (enExample)
TW (1) TW256831B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101753949B1 (ko) 2005-09-01 2017-07-04 백스터 인터내셔널 인코포레이티드 가용화제로서의 산을 포함하는 아가트로반 제제

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
FR2793412B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'argatroban pour administration sous-cutanee
US7687516B2 (en) 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
JP5624766B2 (ja) 2006-09-27 2014-11-12 イーグル・ファーマシューティカルズ・インコーポレーテッド アルコールを含まないアルガトロバン製剤
CN100467022C (zh) * 2007-04-13 2009-03-11 天津市炜杰科技有限公司 21(s)阿加曲班的应用
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
WO2012110971A2 (en) 2011-02-17 2012-08-23 Promed Exports Pvt. Ltd. Method and composition to retard sorption of preservatives to plastics
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2914305T3 (es) * 2017-12-26 2022-06-09 Ind Tech Res Inst Composición para mejorar la solubilidad de sustancias poco solubles, uso de la misma y formulación compleja que contiene la misma
US20240261291A1 (en) * 2021-06-11 2024-08-08 Brien Holden Vision Institute Limited Ophthalmic Compositions and/or Methods for Presbyopia, Mydriasis and/or Ocular Discomfort Management

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1817417C3 (de) * 1968-12-30 1974-04-11 Kalle Ag, 6202 Wiesbaden-Biebrich Z weikomponenten-Diazotypiematerial
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
US4517995A (en) * 1981-10-23 1985-05-21 Lyles Mark B Filters for polynuclear aromatic hydrocarbon-containing smoke
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
EP0489339B1 (en) * 1990-11-27 1996-04-17 Kabushiki Kaisha Toyota Chuo Kenkyusho Brightening chemical polishing solution for hardened steel article and method of using it
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
CA2091715A1 (en) * 1992-03-18 1993-09-19 Mitsubishi Kasei Corporation Argatroban preparations for ophthalmic use
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101753949B1 (ko) 2005-09-01 2017-07-04 백스터 인터내셔널 인코포레이티드 가용화제로서의 산을 포함하는 아가트로반 제제

Also Published As

Publication number Publication date
US5605892A (en) 1997-02-25
TW256831B (enExample) 1995-09-11
EP0621036A1 (en) 1994-10-26
CN1105857A (zh) 1995-08-02
ATE177635T1 (de) 1999-04-15
CA2121723A1 (en) 1994-10-23
AU6059794A (en) 1994-10-27
DE69417087T2 (de) 1999-07-15
DE69417087D1 (de) 1999-04-22
CN1054744C (zh) 2000-07-26
EP0621036B1 (en) 1999-03-17
AU672879B2 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
KR100215533B1 (ko) 아르기닌 아미드 함유 의약 조성물
US7105512B2 (en) Ophthalmic aqueous pharmaceutical preparation
US4942167A (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
JP2020138979A (ja) 眼科用組成物
EP1782816B1 (en) Water-based medicinal composition containing azithromycin and method of preparing the same
KR101906631B1 (ko) 히알루론산 또는 그의 염 및 프로필렌글리콜을 함유하는 점안액
US5034230A (en) Anti-allergic ophthalmics
JPH07228532A (ja) 水性液剤、その有効成分の溶解性向上方法および安定化方法
PT85808B (pt) Processo de preparacao de uma solucao aquosa contendo uma quinolona do acido carboxilico
JPH11302197A (ja) ヒアルロン酸安定化組成物
US5565434A (en) Hexose and pentose prodrugs of ethacrynic acid
US12403126B2 (en) Anesthetic composition and method of anesthetizing the eye
JP4800720B2 (ja) 点眼用組成物
CA2241515A1 (en) Aqueous composition comprising cromoglycic acid
US5654335A (en) Topical use of ethyl ethacrynate for glaucoma treatment
JPH1149698A (ja) 安定性を向上させたラクトフェリンの水性製剤
JPH0383931A (ja) 低刺激性ｇｒｆ経鼻投与製剤
US5093348A (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物
ES2260634T3 (es) Utilizacion de una sal de acido l-ascorbico para preparar una composicion farmaceutica para uso topico oftalmico capaz de mejorar el nivel de acido l-ascorbico del ojo.
AU2025252666A1 (en) Anesthetic composition and method of anesthetizing the eye
ES2322538T3 (es) Inhibidores contra el aumento de la tension ocular causada por irradiacion con laseres, que contienen derivados de 1,4-dihidropiridina.
RU2812900C2 (ru) Анестезирующая композиция и способ анестезирования глаза
EA022390B1 (ru) Способ улучшения биодоступности латанопроста
KR20060121721A (ko) 테트라플루오로벤질 유도체 또는 그의 염을 함유하는주사제용 조성물

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20020415

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030525

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030525

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000